Merriman Wealth Management’s WaferGen Bio-systems, Inc. WGBS Stock Holding History

Merriman Wealth Management’s Portfolio WGBS Stock Details WGBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-3,700	Closed	-$15K	–	181
2016 Q3	$15K	Hold	3,700	–	–	﹤0.01%	132
2016 Q2	$15K	Buy	+3,700	New	+$13.8K	﹤0.01%	105

Other funds holding WGBS

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Merriman Wealth Management's WGBS Position: Q4 2016 in Review

Merriman Wealth Management sold out of WaferGen Bio-systems, Inc. (WGBS) in Q4 2016, closing a stake of 3,700 shares — an estimated $15K sold.

Merriman Wealth Management first reported a position in WGBS in Q2 2016 and held it in 2 quarters. The position peaked at $15K in Q3 2016. 9 funds tracked by Wall St. Rank hold WGBS as of Q4 2016.

Merriman Wealth Management reported no remaining WaferGen Bio-systems, Inc. position as of Q4 2016 after selling out during the quarter.
Merriman Wealth Management sold 3,700 WaferGen Bio-systems, Inc. shares in Q4 2016, an estimated $15K.
Merriman Wealth Management first reported a position in WaferGen Bio-systems, Inc. in Q2 2016 and held it in 2 quarters.
Merriman Wealth Management's WaferGen Bio-systems, Inc. position peaked at $15K in Q3 2016.
9 funds tracked by Wall St. Rank held WaferGen Bio-systems, Inc. as of Q4 2016.

Based on Merriman Wealth Management's 13F filing for Q4 2016, filed 8 Feb 2017.